ArticleBMC pediatrics2026
Clinical characteristics and etiologies of hypomagnesemia in children: a single-center retrospective cohort study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo summarize the etiologies, clinical manifestations, and genetic profiles of children with hypomagnesemia admitted to the Department of Pediatric Endocrinology, Metabolism and Genetics (PEGM).
methodsA retrospective analysis was conducted on clinical data and genetic testing results of 28 children diagnosed with hypomagnesemia at our medical center between September 2018 and October 2025.
resultsTwenty-eight patients were included in the analysis. The median age at onset of the cohort was 9.28 (5.00, 12.30) years, and the median height standard deviation score (SDS) was - 1.28 (- 1.95, 0.11). This study involved Gitelman syndrome (GS) (11/28), HNF1B-related maturity-onset diabetes of the young (HNF1B-related MODY) (6/28), hereditary hypomagnesemia with secondary hypocalcemia (HSH) (3/28). Patients with HSH had the earliest onset and the lowest serum magnesium concentrations. Short stature was a common feature among patients with GS. HSH patients had fractional excretion of magnesium (FEMg) < 2%, while GS and HNF1B-MODY presented FEMg > 3% with renal magnesium loss. Metabolic alkalosis was detected in GS and HNF1B-MODY, but acid-base status remained normal in HSH. GS was characterized by hypocalciuria, whereas hypercalciuria occurred in hypoparathyroidism and Williams syndrome. All HNF1B-MODY patients exhibited some degree of renal structural anomalies on ultrasound. A total of ten genes and chromosomal microdeletions were identified: SLC12A3, MT-TF, MT-RNR1, TRPM6, HNF1B deletion, 17q12 deletion, 22q11.21 deletion, CASR, 7q11.23 deletion, and AIRE.
conclusionPersistent hypomagnesemia in children attending the PEGM department is predominantly hereditary, with GS as the leading cause. Before genetic confirmation, differential diagnosis can be guided by renal magnesium excretion rate, blood gas analysis, calciuria evaluation, renal imaging, growth status, and clinical response to magnesium supplementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.